Clinical trial
Expressive Writing and Adjustment to Metastatic Breast Cancer
NCT00624156 is registered in ClinicalTrials.gov with Memorial Sloan Kettering Cancer Center as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Expressive Writing and Adjustment to Metastatic Breast Cancer
- Lead sponsor
- Memorial Sloan Kettering Cancer Center
- Phase
- Observational
- Overall status
- Completed
- Start date
- February 29, 2008
- Completion date
- January 31, 2012
- Enrollment
- 98 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
metastatic breast cancer